However, unlike fully developed tumors, they are not likely to have acquired many genetic changes and are therefore unlikely to have gained resistance to PARP inhibitors.
Sin embargo, a diferencia de los tumores completamente desarrollados, es improbable que hayan adquirido muchos cambios genéticos y, por tanto, hay pocas posibilidades de que hayan desarrollado resistencia a los inhibidores de la PARP.